A common deletion in the uridine diphosphate glucuronyltransferase (ugt) 2b17 gene is a strong determinant of androgen excretion in healthy

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 3, 2009, Pages 1005-1011

  Juul, A ^a,d   SOrensen K ^a   Aksglaede, L ^a   Garn, I ^a   Rajpert De Meyts, E ^a   Hullstein, I ^b,c   Hemmersbach, P ^b,c   Ottesen, A M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANEDIOL; EPITESTOSTERONE; ESTRADIOL; FOLLITROPIN; GLUCURONOSYLTRANSFERASE; HORMONE RECEPTOR; LUTEINIZING HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCURONYLTRANSFERASE 2B17;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; GAS CHROMATOGRAPHY; GENE DELETION; GENOTYPE; HOMOZYGOSITY; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; MALE; MASS SPECTROMETER; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUBERTY; QUANTITATIVE ANALYSIS; SCHOOL CHILD; URINARY EXCRETION;

EID: 62349110318     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1984     Document Type: Article

References (34)

1. Navarro VM, Castellano JM, Garcia-Galiano D, Tena-Sempere M 2007Neuroendocrine factors in the initiation of puberty: the emergent role of kisspeptin. Rev Endocr Metab Disord 8:11-20
2. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguigiion JP 2003 The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 24:668-693
3. Andersson AM, Jensen TK, Juul A, Petersen JH, Jorgensen T, Skakkebaek NE 2007 Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. J Clin Endocrinal Metab 92: 4696-4705
4. Rajpert-De Meyts E, Leffers H, Petersen JH, Andersen AG, Carlsen E, Jørgensen N, Skakkebaek NE 2002 CAG repeat length in androgen-receptor gene and reproductive variables in fertile and infertile men. Lancet 359:44-46
5. Belanger A, PelletierG,LabrieF,BarbierO, Chouinard S 2003 Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 14:473-479
6. JakobssonJ, Ekström L, Inotsume N, Garle M, Lorentzon M, Ohlsson C, Roh HK. Carlström K, Rane A 2006 Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J Clin Endocrinal Metab 91:687-693
7. Swanson C, Mellström D, Lorentzon M, Vandenput L, Jakobsson J, Rane A, Karlsson M, Ljunggren O, Smith U, Eriksson AL, Bélanger A, Labrie F, Ohlsson C 2007 The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men. J Clin Endocrinol Metab 92:4878-4882
8. Schulze JJ, Lundmark J, Garle M, Skilving I, Ekstrom L, Rane A 2008 Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab 93:2500-2506
9. Marshall WA, Tanner JM 1969 Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291-303
10. Marshall WA, Tanner JM 1970 Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-23
11. Zachmann M, Prader A, Kind HP, Hafliger H, Budliger H 1974 Testicular volume during adolescence. Cross sectional and longitudinal studies. Helv Paediatr Acta 29:61-72
12. Andersson AM, Juul A, Petersen JH, Muller J, Groome NP, Skakkebaek NE 1997 Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab 82:3976-3981
13. Ottesen AM, Gam ID, Aksglaede L, Juul A, Meyts ERD 2007 A simple screening method for detection of Klinefelter syndrome and other X-chromosome aneuploidies based on copy number of the androgen receptor gene. Mol Hum Reprod 13:745-750
14. Pattyn F, Robbrecht P, De Paepe A, Speleman F, Vandesompele J 2006 RTPrimerDB: the real-time PCR primer and probe database, major update 2006. Nucleic Acids Res 34(Database issue):D684-D688
15. Mau Kai C, Juul A, McElreavey K, Ottesen AM, Garn ID. Main KM, Loft A, Jørgensen N, Skakkebaek NE, Andersen AN, Rajpert-De Meyts E 2008 Sons conceived by assisted reproduction techniques inherit deletions in the azoospermia factor (AZF) region ofthe Y chromosome and the DAZ gene copy number. Hum Reprod 23:1669-1678
16. Mareck U, Geyer J, Opfermann G, Thevis M, Schanzer W 2008 Factors influencing the steroid profile in doping control analysis. J Mass Spectrom 43: 877-891
17. World Anti-Doping Agency 2004 Reporting and evaluation guidance for testosterone, epitestosterone, T/E ratio and other endogenous steroids.www.wada-ama.org/rtecontent/document/end-steroids-aug-04.pdf
18. 85Y). Cancer Epidemiol Biomarkers Prev 9:329-333
19. Anderson CA, Duffy DL, Martin NG, Visscher PM 2007 Estimation of variance components for age at menarche in twin families. Behav Genet 37:668-677
20. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno Jr JS, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley Jr WF, Aparicio SA, Colledge WH 2003 The GPR54 gene as a regulator of puberty. N Engl J Med 349:1614-1627
21. Teles MG, Bianco SD, Brito VN, Trarbach EB, Kuohung W, Xu S, Seminara SB, Mendonca BB, Kaiser UB, Latronico AC 2008 A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 358:709-715
22. MareckU, GeyerH, Flenker U,Piper T,Thevis M, SchanzerW 2007 Detection of dehydroepiandrosterone misuse by means of gas chromatography- combustion-isotope ratio mass spectrometry. Eur J Mass Spectrom 13:419-426
23. RaynaudE,AudranM,PagésJC,FédouC,BrunJF,ChanalJL, OrsettiA1993 Determination of urinary testosterone and epitestosterone during pubertal development: a cross-sectional study in 141 normal-male subjects. Clin Endocrinol (Oxf) 38:353-359
24. Raynaud E, Audran M, Pages JC, Brun JF, Fedou C, Chanal JL, Orsetti A1993 [Urinary-excretion of testosterone and epitestosterone glucuronides in preadolescents and adolescents]. Pathol Biol 41:159-163 (French)
25. Schweizer C, Cardis C, Cauderay L, Rivier L, Saugy M 1997 T/E ratio variations through puberty in male adolescents. In: Schanzer W, Geyer H, Gotzmann A, Mareck-Engelke LT, eds. Recent advances in doping analysis. Koln, Germany: Sport und Buch Strauss; 159-171
26. Oftebro H 1992 Evaluating an abnormal urinary steroid profile. Lancet 339: 941-942
27. Cawley AT, Flenker U 2008 The application of carbon isotope ratio mass spectrometry to doping control. J Mass Spectrom 43:854-864
28. DehenninL,Delgado A, Peres G1994 Urinary profile of androgen metabolites at different stages of pubertal development in a population of sporting male subjects. Eur J Endocrinol 130:53-59
29. Schulze JJ, Lorentzon M, Ohlsson C, Lundmark J, Roh HK, Rane A, Ekström L 200 8 Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymes. Pharmacogenet Genom 18:477-485
30. Borts DJ, Bowers LD 2000 Direct measurement of urinary testosterone and epitestosterone conjugates using high-performance liquid chromatography/ tandem mass spectrometry. J Mass Spectrom 35:50-61
31. Park J, Chen L, Ratnashinge L, Sellers TA, Tanner JP, Lee JH, Dossett N, Lang N, Kadlubar FF, Ambrosone CB, Zachariah B, Heysek RV, Patterson S, Pow-Sang J 2006 Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men. Cancer Epidemiol Biomarkers Prev 15:1473-1478
32. Bélanger G, Beaulieu M, Marcotte B, Lévesque E, Guillemette C, Hum DW, Bélanger A 1995 Expression of transcripts encoding steroid UDP-glucuronosyltransferases in human prostate hyperplastic tissue and the LNCaP cell line. Mol Cell Endocrinol 113:165-173
33. Olsson M, Lindström S, Häggkvist B, Adami HO, Bäiter K, Stattin P, Ask B, Rane A, Ekström L, Grönberg H 2008 The UGT2B17 gene deletion is not associated with prostate cancer risk. Prostate 68:571-575
34. Catlin DH, Leder BZ, Ahrens BD, Hatton CK, Finkelstein JS 2002 Effects of androstenedione administration on epitestosterone metabolism in men. Steroids 67:559-564